After advisers backed adding BPC-157, TB-500, KPV and others to the 503A bulks list, pharmacists are waiting on the FDA's final decision.
Recap by typeshit. Full story at Pharmacy Times.
Inc. reports that some Georgia clinics are still marketing an unapproved Lilly weight loss drug even as the company moves against its sale.
South Africa's medicines regulator now spells out how synthetic peptide medicines can be legally registered and sold, a first for the country.
Officers say the seized pharmaceuticals were worth $280,106.20 in total, part of a wider push against smuggled weight loss and peptide products.
West Midlands Police and the UK regulator raided an industrial unit and also found packaging for around 30,000 more pens.
13:47
Ketcham runs through the habits she credits for her 90 pound loss on tirzepatide. Her personal take, not medical advice, so check with a doctor.
9:07
The endocrinologist takes on whether people can get retatrutide now, setting gray market supply against the results from Lilly's actual trials.
Loading…